Recombinant human interleukin-2 (rhIL-2) (Zhejiang Hisun Pharma)
重组人白介素-2（125Ser）（浙江海正药业）
Report date: 2025/06/26 11:33:00
Base Information
Drug NameRecombinant human interleukin-2 (rhIL-2) (Zhejiang Hisun Pharma)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusN/A
Highest Status in ChinaN/A
Originator CompaniesZhejiang Hisun Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesZhejiang Hisun Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive Indications